The Vanguard Group - 23-1945930 13D and 13G filings for AnaptysBio, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 4:58 pm Sale | 2023-12-29 | 13G | AnaptysBio, Inc. ANAB | The Vanguard Group - 23-1945930 | 1,380,115 5.190% | -396,793 (-22.33%) | Filing |
| 2023-02-09 11:07 am Sale | 2022-12-30 | 13G | AnaptysBio, Inc. ANAB | The Vanguard Group - 23-1945930 | 1,776,908 6.250% | -65,775 (-3.57%) | Filing |
| 2022-02-09 3:24 pm Sale | 2021-12-31 | 13G | AnaptysBio, Inc. ANAB | The Vanguard Group - 23-1945930 | 1,842,683 6.670% | -377,638 (-17.01%) | Filing |
| 2021-02-10 10:30 am Purchase | 2020-12-31 | 13G | AnaptysBio, Inc. ANAB | The Vanguard Group - 23-1945930 | 2,220,321 8.120% | 25,660 (+1.17%) | Filing |
| 2020-02-12 09:26 am Purchase | 2019-12-31 | 13G | AnaptysBio, Inc. ANAB | The Vanguard Group - 23-1945930 | 2,194,661 8.080% | 305,460 (+16.17%) | Filing |